DOS IGUAL A UNO MEDICINA CREATIVA SL
Company details
- Defunct NIF/CIF: B85090207
-
-
-
-
Address: AVDA CONSTITUCION 73 Ptl7 6º - IZQUIERDA (COSLADA)
-
-
Featured products:
More information on DOS IGUAL A UNO MEDICINA CREATIVA SL
-
26/05/2008 | BORME act no.: 259438 | Register: MADRIDCeses/Dimisiones
-
26/05/2008 | BORME act no.: 259438 | Register: MADRIDNombramientos
-
26/05/2008 | BORME act no.: 259438 | Register: MADRIDDisolución
-
05/06/2007 | BORME act no.: 305112 | Register: MADRIDConstitución
-
05/06/2007 | BORME act no.: 305112 | Register: MADRIDNombramientos
Other information
The CIF assigned to DOS IGUAL A UNO MEDICINA CREATIVA SL is B85090207, while its current business status is defunct. The company operates in the economic sector identified by the CNAE 7410 - Actividades de diseño especializado. In addition, its activity corresponds to the SIC classification 8711 - Servicios de ingeniería.
The template of DOS IGUAL A UNO MEDICINA CREATIVA SL includes Between 10 and 49 employees, and the company reports an annual turnover of less than 2 million euros. DOS IGUAL A UNO MEDICINA CREATIVA SL is registered in the Mercantile Registry of Madrid and accumulates a total of 2 registration charges. The most recent announcement in Borme was published on 26/05/2008, while its last deposit of ordinary annual accounts is related to the - exercise.
If you want to obtain contact information for DOS IGUAL A UNO MEDICINA CREATIVA SL, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about DOS IGUAL A UNO MEDICINA CREATIVA SL, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about DOS IGUAL A UNO MEDICINA CREATIVA SL comes from official data sources and is automatically updated every day.
Do you want to know more about DOS IGUAL A UNO MEDICINA CREATIVA SL??
Find out more about this company by consulting these reports: